Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells

Biochem Biophys Res Commun. 2000 Dec 29;279(3):846-52. doi: 10.1006/bbrc.2000.4034.

Abstract

NK4 composed of the N-terminal hairpin and subsequent four-kringle domains of hepatocyte growth factor (HGF) is bifunctional, acting as a competitive antagonist for HGF and an angiogenesis inhibitor. In this study, we determined whether or not four-kringle domains of HGF (K1-4) have anti-angiogenic activity. For this purpose, we prepared recombinant K1-4 and NK4, using the baculovirus expression system. Although NK4 antagonized HGF-induced DNA synthesis of rat hepatocytes, cell scattering of MDCK cells and the c-Met/HGF receptor tyrosine phosphorylation in endothelial cells, K1-4 failed to antagonize HGF-induced DNA synthesis, cell scattering and the c-Met/HGF receptor tyrosine phosphorylation in endothelial cells, thus, indicating that K1-4 lacks HGF-antagonist activity. However, endothelial proliferation and migration induced by HGF was inhibited by K1-4, similar to the case seen with NK4. Furthermore, K1-4 inhibited the proliferation and migration of human dermal microvascular endothelial cells induced by vascular endothelial growth factor or by basic fibroblast growth factor. We propose that kringle 1-4 of HGF inhibits angiogenic responses in endothelial cells, independently of HGF-c-Met signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors*
  • Animals
  • CHO Cells
  • Cell Division / drug effects
  • Cell Movement / drug effects*
  • Cricetinae
  • Endothelial Growth Factors / physiology
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology
  • Fibroblast Growth Factor 2 / physiology
  • Hepatocyte Growth Factor / chemistry
  • Hepatocyte Growth Factor / pharmacology*
  • Humans
  • Kringles*
  • Lymphokines / physiology
  • Neovascularization, Physiologic
  • Phosphorylation
  • Protein Conformation
  • Proto-Oncogene Proteins c-met / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / pharmacology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inhibitors
  • Endothelial Growth Factors
  • Lymphokines
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met